Literature DB >> 16050014

New IBD genes?

D McGovern1, T Ahmad.   

Abstract

Mesh:

Year:  2005        PMID: 16050014      PMCID: PMC1774884          DOI: 10.1136/gut.2004.048918

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  12 in total

1.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.

Authors:  J D Rioux; M J Daly; M S Silverberg; K Lindblad; H Steinhart; Z Cohen; T Delmonte; K Kocher; K Miller; S Guschwan; E J Kulbokas; S O'Leary; E Winchester; K Dewar; T Green; V Stone; C Chow; A Cohen; D Langelier; G Lapointe; D Gaudet; J Faith; N Branco; S B Bull; R S McLeod; A M Griffiths; A Bitton; G R Greenberg; E S Lander; K A Siminovitch; T J Hudson
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

2.  Genetic variation in DLG5 is associated with inflammatory bowel disease.

Authors:  Monika Stoll; Brit Corneliussen; Christine M Costello; Georg H Waetzig; Bjorn Mellgard; W Andreas Koch; Philip Rosenstiel; Mario Albrecht; Peter J P Croucher; Dirk Seegert; Susanna Nikolaus; Jochen Hampe; Thomas Lengauer; Stefan Pierrou; Ulrich R Foelsch; Christopher G Mathew; Maria Lagerstrom-Fermer; Stefan Schreiber
Journal:  Nat Genet       Date:  2004-04-11       Impact factor: 38.330

3.  A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease.

Authors:  Bill Newman; Xiangjun Gu; Richard Wintle; David Cescon; Mehrdad Yazdanpanah; Xiangdong Liu; Vanya Peltekova; Mark Van Oene; Christopher I Amos; Katherine A Siminovitch
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

4.  Association of DLG5 R30Q variant with inflammatory bowel disease.

Authors:  Mark J Daly; Alexandra V Pearce; Lisa Farwell; Sheila A Fisher; Anna Latiano; Natalie J Prescott; Alastair Forbes; John Mansfield; Jeremy Sanderson; Diane Langelier; Albert Cohen; Alain Bitton; Gary Wild; Cathryn M Lewis; Vito Annese; Christopher G Mathew; John D Rioux
Journal:  Eur J Hum Genet       Date:  2005-07       Impact factor: 4.246

5.  A genome-wide search identifies potential new susceptibility loci for Crohn's disease.

Authors:  Y Ma; J D Ohmen; Z Li; L G Bentley; C McElree; S Pressman; S R Targan; N Fischel-Ghodsian; J I Rotter; H Yang
Journal:  Inflamm Bowel Dis       Date:  1999-11       Impact factor: 5.325

6.  Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.

Authors:  H-P Török; J Glas; L Tonenchi; P Lohse; B Müller-Myhsok; O Limbersky; C Neugebauer; F Schnitzler; J Seiderer; C Tillack; S Brand; G Brünnler; P Jagiello; J T Epplen; T Griga; W Klein; U Schiemann; M Folwaczny; T Ochsenkühn; C Folwaczny
Journal:  Gut       Date:  2005-06-14       Impact factor: 23.059

7.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

9.  Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.

Authors:  A Armuzzi; T Ahmad; K-L Ling; A de Silva; S Cullen; D van Heel; T R Orchard; K I Welsh; S E Marshall; D P Jewell
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

10.  NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.

Authors:  J Wehkamp; J Harder; M Weichenthal; M Schwab; E Schäffeler; M Schlee; K R Herrlinger; A Stallmach; F Noack; P Fritz; J M Schröder; C L Bevins; K Fellermann; E F Stange
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

View more
  2 in total

Review 1.  The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.

Authors:  Maja Stojancevic; Karmen Stankov; Momir Mikov
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

2.  The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course.

Authors:  Jessica Mwinyi; Christa Grete-Wenger; Jyrki J Eloranta; Gerd A Kullak-Ublick
Journal:  PPAR Res       Date:  2012-02-14       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.